| treatment | comparator | All cause death (0) | Coronary event (1) | Cardiovascular death (2) | Death from cancer (3) | Fatal MI (4) | Heart failure (5) | Long term death (6) | Fatal stroke (7) | Non fatal stroke (8) | Non fatal MI (9) | stroke (fatal and non fatal) (10) | myocardial infarction (fatal and non fatal) (11) | cardiovascular events (12) | cardiac event (fatal and non fatal ) (13) | non cardiovascular death (14) | macrovascular events (15) | microvascular events (16) | nephropathy (17) | retinopathy (18) | macrovascular or microvascular events (19) | fatal HF (20) | Peripheral vascular events (21) | long term cardiovascular events (22) | vision loss (23) | severe hypoglycemia (24) | Edit | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glargine | diabetes type 2, in all type of patients | vs premixed insulin analogues | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
